Primary protocol to this study is to develop a natural remedy to prevent diabetes mellitus in pre-diabetic state and elaborate the effectiveness of polyherbal formulation for carrying out Phase-II, III and IV. It also aimed at to see the level of difference of glucose tolerance and impaired fasting glucose and impaired glucose tolerance between pre-diabetic and diabetic to evaluate the potential benefit for treatment of insulin resistance and sensitivity. To see the for prevention of Diabetes Mellitus (DM) and stopping / delaying the onset of DM.
This study is a clinical trial study to evaluate the potential of prevention in pre-diabetics and to prevent onset of diabetes mellitus. For this purpose, volunteers will be enrolled in the study by observing the Helsinki Declaration for clinical trials. volunteers will be screened for the impaired glucose tolerance or impaired fasting glucose or at risk to develop diabetes mellitus type 2. On screening, pre-diabetics and early onset diabetics with no previous history of treatment etc will be grouped into A and B. Biochemical evaluations will be carried out at base line and followed by three weeks intervention and evaluation of biomarkers and at sixth week for further evaluation. Collected data will be evaluated for primary out comes and secondary out come. statistical analysis will be done. One year followup of participants was conducted.
Study Type
OBSERVATIONAL
Enrollment
57
Test candidate will be administered per oral before / with meal in two divided doses
Hashmi Dawakhana
Khairpur Tamewali, Punjab Province, Pakistan
University College of Conventional Medicine
Bahawalpur, Pakistan
Fasting Glucose Tolerance (FGT)
enhancement of fasting glucose tolerance (\<100mg/dl)
Time frame: six weeks
Glucose Tolerance (GT)
enhancement of oral glucose tolerance (\<140mg/dl)
Time frame: six weeks
HB-A1c
improvement in glycated hemoglobin (HB-A1c) percentage \<6%,
Time frame: six week
Lipid Profile
serum Cholesterol level (mg/dl)
Time frame: six weeks
Lipid Profile
Serum Triglycerides (mg/dl)
Time frame: Six Weeks
Lipid Profile
Serum Low Density Lipids (LDL) (mg/dl)
Time frame: Six week
Lipid Profile
Serum High Density Lipids (HDL) (mg/dl)
Time frame: six week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.